The House of Representatives is planning to consider a bill Friday that could give a big cash infusion to medical research, which has been struggling in recent years. But the bill would also tweak the government’s drug approval process in a way that makes some researchers nervous. Jerry Avorn, professor of medicine at Brigham & Women’s Hospital, is quoted.
Trending News
Research Provides Clues to Spleen’s Role in Coronary Artery Disease
Genetic variants may drive visible changes in the spleen that contribute to heart disease
Patient Who Received Pig Kidney Becomes First To Progress to Human Kidney Transplant
Study shows xenotransplantation can serve as a bridge for patients with end-stage kidney disease
Pilots, Flight Attendants Have Greater Risk of Radiation-Related Cancer Death Than Other Professions
Findings support efforts to protect U.S. aircrews from cosmic radiation exposure